Quick answers
- What is Lidocaine used for?
- The FDA-approved label (Xylocaine, Sportpharm LLC, February 3, 2026) says: “Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Lidocaine have a boxed warning?
- The label we quote has no boxed warning, but 14 of 275 FDA labels for this medicine do. Check the label of your own product.
- Is there a shortage of Lidocaine?
- The FDA drug shortage list shows “Current shortage” for a product of this medicine (updated October 21, 2026). Ask your pharmacist about alternatives.
- Has Lidocaine been recalled?
- FDA enforcement reports list 31 recalls of products of this medicine; the newest started August 31, 2026 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Lidocaine?
- 84 companies list prescription products of Lidocaine in the FDA NDC Directory, including HF Acquisition Co LLC, DBA HealthFirst, Eugia US LLC and Medical Purchasing Solutions, LLC.
What Lidocaine is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard …
— FDA label: Xylocaine, Sportpharm LLC, effective February 3, 2026. Read the full label on DailyMed →
The FDA has 275 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
14 of 275 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution · Ointment · Patch · Solution · Jelly · Injection · System · Gel |
|---|---|
| Route | Infiltration · Topical · Perineural · Epidural · Intracaudal · Intravenous |
| Prescription products | 369 in the FDA NDC Directory |
| Brand names | Xylocaine Mpf, Xylocaine, Lidocaine Viscous, Lidocaine Hydrochloride and Dextrose, Bondlido, Lidocan III, Lidocan, Lidox 5 Patch, Lidocan V, Lidoderm, Lidocan Vi, Lidocan Vii |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| lidocaine 36 mg patch | Brand: Ztlido | $12.31 per patch |
| lidocaine 5% ointment | Generic | $0.1411–$0.1641 per gram 18 packages, lowest to highest |
| lidocaine 5% patch | Generic | $1.99 per patch |
| lidocaine 700 mg patch | Generic | $1.99 per patch |
| lidocaine hydrochloride 10 mg/mL injection, solution | Generic | $0.0542–$0.8000 per mL 25 packages, lowest to highest |
| lidocaine hydrochloride 20 mg/mL injection, solution | Generic | $0.0714–$0.3487 per mL 11 packages, lowest to highest |
| lidocaine hydrochloride 20 mg/mL jelly | Generic | $0.7040–$3.20 per mL 4 packages, lowest to highest |
| lidocaine hydrochloride 20 mg/mL solution | Generic | $0.0827 per mL |
| lidocaine hydrochloride 40 mg/mL solution | Generic | $0.2324 per mL |
| lidocaine hydrochloride anhydrous 10 mg/mL injection, solution | Generic | $0.0542–$0.8000 per mL 8 packages, lowest to highest |
| lidocaine hydrochloride anhydrous 20 mg/mL injection, solution | Generic | $0.0714–$0.3487 per mL 6 packages, lowest to highest |
| lidocaine hydrochloride anhydrous 20 mg/mL jelly | Generic | $0.5136–$0.9010 per mL 2 packages, lowest to highest |
| lidocaine hydrochloride anhydrous 20 mg/mL solution | Generic | $0.0827 per mL |
| lidocaine hydrochloride anhydrous 40 mg/mL solution | Generic | $0.2324 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- HF Acquisition Co LLC, DBA HealthFirst33 products
- Eugia US LLC23 products
- Medical Purchasing Solutions, LLC20 products
- Fresenius Kabi USA, LLC19 products
- Asclemed USA, Inc.16 products
- Henry Schein, Inc.16 products
- Bryant Ranch Prepack16 products
- Hospira, Inc.12 products
- Lifestar Pharma LLC12 products
- Hikma Pharmaceuticals USA Inc.11 products
- A-S Medication Solutions11 products
- Remedyrepack Inc.10 products
- Direct_Rx10 products
- Preferred Pharmaceuticals Inc.9 products
- Sportpharm LLC9 products
- NorthStar RxLLC7 products
- ProPharma Distribution7 products
- Puretek Corporation7 products
- Proficient Rx LP7 products
- Advanced Rx Pharmacy of Tennessee, LLC6 products
- International Medication Systems, Limited6 products
- Advanced Rx of Tennessee, LLC6 products
- Phoenix RX LLC6 products
- Cardinal Health 107, LLC5 products
- NuCare Pharmaceuticals, Inc.5 products
- Anthea Pharma Private Limited4 products
- Huons Co., Ltd.4 products
- Brookfield Pharmaceuticals, LLC.4 products
- Camber Pharmaceuticals, Inc.4 products
- PAI Holdings, LLC dba PAI Pharma3 products
- Atlantic Biologicals Corp.3 products
- Golden State Medical Supply, Inc.3 products
- Sun Pharmaceutical Industries, Inc.3 products
- Amneal Pharmaceuticals LLC3 products
- Quality Care Products, LLC3 products
- Trifluent Pharma, LLC3 products
- Civica, Inc.2 products
- Xttrium Laboratories, Inc.2 products
- Avenacy, LLC2 products
- Baxter Healthcare Corporation2 products
- Aurobindo Pharma Limited2 products
- Sandoz Inc2 products
- Novagenix Labs LLC2 products
- McKesson Corporation dba SKY Packaging2 products
- Actavis Pharma, Inc.2 products
- St. Mary's Medical Park Pharmacy2 products
- Chartwell RX, LLC2 products
- Advagen Pharma Ltd1 product
- Novitium Pharma LLC1 product
- Major Pharmaceuticals1 product
- American Health Packaging1 product
- Marlex Pharmaceuticals, Inc.1 product
- The J. Molner Company LLC1 product
- HF Acquisition Co. LLC, DBA Health First1 product
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 product
- Precision Dose, Inc.1 product
- Armas Pharmaceuticals Inc.1 product
- Sentiss Pharmaceuticals LLC1 product
- NorthStar Rx LLC1 product
- Alembic Pharmaceuticals Inc.1 product
- YARAL Pharma Inc.1 product
- MEDRx USA, Inc.1 product
- Injecta Medcial LLC1 product
- Fougera Pharmaceuticals, LLC1 product
- Encube Ethicals, Inc.1 product
- Alembic Pharmaceuticals Limited1 product
- Ascend Laboratories, LLC1 product
- Par Health USA, LLC1 product
- Glenmark Pharmaceuticals Inc., USA1 product
- Terrain Pharmaceuticals, Inc.1 product
- TPU Pharma, Inc.1 product
- Quagen Pharmaceuticals LLC1 product
- AvKARE1 product
- Septodont, Inc.1 product
- Medcore LLC1 product
- Kesin Pharma Corporation1 product
- Macleods Pharmaceuticals Limited1 product
- Scilex Pharmaceuticals Inc.1 product
- Chartwell Governmental & Specialty RX, LLC.1 product
- Sagent Pharmaceuticals1 product
- Spectra Medical Devices, LLC1 product
- Thea Pharma Inc.1 product
- B. Braun Medical Inc.1 product
- Lannett Company, Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA006488 XYLOCAINE, XYLOCAINE W/ EPINEPHRINE | Fresenius Kabi USA | November 19, 1948 | 75, latest October 30, 2024 2024: Labeling · 2018: Labeling · 2017: Manufacturing (CMC) |
| NDA017584 LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE | Fresenius Kabi USA | March 26, 1976 | 26, latest August 17, 2026 2026: Labeling · 1996: Labeling · 1995: Manufacturing (CMC) |
| NDA018461 LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | Baxter Hlthcare | April 22, 1981 | 45, latest February 7, 2017 2017: Labeling · 2015: Manufacturing (CMC) · 2012: Labeling |
| NDA020612 LIDODERM | Teikoku Pharma USA | March 19, 1999 | 8, latest November 2, 2018 2018: Labeling · 2016: Manufacturing (CMC) · 2015: Labeling |
| NDA022221 AKTEN | Thea Pharma | October 7, 2008 | 4, latest November 21, 2025 2025: Labeling · 2022: Labeling · 2014: Labeling |
| NDA207962 ZTLIDO | Scilex Pharms | February 28, 2018 | 2, latest April 8, 2021 2021: Efficacy · 2018: Labeling |
| NDA215029 BONDLIDO | Medrx USA | September 24, 2025 | — |
Generic approvals (61)
- ANDA080407West-Ward Pharms Int · February 14, 1972
- ANDA080198Fougera Pharms Inc · June 30, 1972
- ANDA080408Hospira · September 28, 1972
- ANDA083158Hospira · October 31, 1972
- ANDA084625Hikma · June 16, 1975
- ANDA083173Intl Medication · September 17, 1975
- ANDA086283Intl Medication · August 7, 1979
- ANDA086364Intl Medication · March 6, 1980
- ANDA086724Sun Pharma Canada · August 17, 1981
- ANDA087872Pharmobedient · November 18, 1982
- ANDA087881Pharmobedient · November 18, 1982
- ANDA088294Hospira · May 16, 1984
- ANDA088295Hospira · May 16, 1984
- ANDA088328Hospira · May 17, 1984
- ANDA088329Hospira · May 17, 1984
- ANDA088299Hospira · July 31, 1984
- ANDA088325Hospira · July 31, 1984
- ANDA088327Hospira · July 31, 1984
- ANDA088803Hikma · April 3, 1985
- ANDA088802Hikma · April 26, 1985
- ANDA088586Fresenius Kabi USA · July 24, 1985
- ANDA040078Hospira · June 23, 1995
- ANDA040014Hikma · July 10, 1995
- ANDA040302Hospira · September 28, 1998
- ANDA040433Sentiss · February 12, 2003
- ANDA040708Chartwell Molecular · February 27, 2007
- ANDA040710Lannett Co Inc · February 27, 2007
- ANDA040911Septodont Inc · May 23, 2011
- ANDA200675Actavis Labs Ut Inc · August 23, 2012
- ANDA203040Eugia Pharma · March 14, 2013
- ANDA203082Eugia Pharma · March 14, 2013
- ANDA204494Pai Holdings Pharm · March 12, 2014
- ANDA201094Sagent Pharms Inc · April 28, 2014
- ANDA206297Amneal Pharms · August 7, 2015
- ANDA205318Encube · February 1, 2016
- ANDA206498Glenmark Pharms Ltd · September 9, 2016
- ANDA207810Alkem Labs Ltd · March 10, 2017
- ANDA207182Eugia Pharma · October 30, 2017
- ANDA208017Spectra Mdcl Devices · April 18, 2018
- ANDA208474B Braun Medical · August 3, 2018
Showing the 40 earliest of 61.
Shortage status
Current shortage · updated October 21, 2026 · first posted February 22, 2012
| Product | Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) |
|---|---|
| Availability | Available |
| Company | Hospira, Inc., a Pfizer Company |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
August 31, 2026 · Class II · Ongoing · D-0848-2026
Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5 — SUN PHARMA /TARO
-
July 16, 2026 · Class II · Ongoing · D-0726-2026
Presence of Particulate Matter: Hair was found in products
Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-208-05; NDC Vial: 63323-208-01 — Fresenius Kabi USA, LLC
-
July 16, 2026 · Class II · Ongoing · D-0728-2026
Presence of Particulate Matter: Hair was found in products
Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01 — Fresenius Kabi USA, LLC
-
July 16, 2026 · Class II · Ongoing · D-0729-2026
Presence of Particulate Matter: Hair was found in products
Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03 — Fresenius Kabi USA, LLC
-
July 15, 2026 · Class III · Ongoing · D-0713-2026
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01. — Asclemed USA Inc.
-
June 8, 2026 · Class II · Ongoing · D-0659-2026
Lack of Assurance of Sterility
Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01. — Asclemed USA Inc.
-
May 18, 2026 · Class III · Ongoing · D-0552-2026
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02 — Eugia US LLC
-
May 12, 2026 · Class II · Ongoing · D-0554-2026
Lack of Assurance of Sterility
Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1. — Spectra Medical Devices, Llc
-
April 2, 2026 · Class II · Ongoing · D-0529-2026
Lack of Assurance of Sterility
Lidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials, Rx only, Manufactured by: Huons Co, Ltd, Chungcheongbuk-do, Korea NDC 73293-0001-1 (vial), NDC 73293-0001-2 (10 count carton); Distributed by: — Huons Co., Ltd.
-
April 2, 2026 · Class II · Ongoing · D-0532-2026
Lack of Assurance of Sterility
Lidocaine HCl Injection, USP, 2%, 100 mg/5mL (20 mg/mL), 5 mL Single-Dose Vials, Rx only, Manufactured by: Huons Co., Ltd., 100 Bio valley-ro, Jecheon-si, Chungchengbuk-do, Korea, NDC 73293-0003-1 (vial), NDC 73293-0003- — Huons Co., Ltd.
-
April 20, 2023 · Class III · Ongoing · D-0556-2023
Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive patch contains.
Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (63629-8755-1), Rx only, each patch contains: 700 mg (50mg per gram adhesive) in an aqueous base, Manufactured by: Actavis Laboratories — Bryant Ranch Prepack, Inc.
-
April 13, 2022 · Class II · Terminated · D-1068-2022
cGMP deviations: Temperature abuse
Lidocaine Patch 5%, 30-count box, Rx only, MFG: Teva Pharma USA, NDC 0591-3525-30 — Mckesson Medical-Surgical Inc. Corporate Office
-
April 13, 2022 · Class II · Terminated · D-1043-2022
cGMP deviations: Temperature abuse
Lidocaine Patch 5%, 30-count carton, Rx only, MFG: Qualitest Products, NDC 0603-1880-16 — Mckesson Medical-Surgical Inc. Corporate Office
-
April 13, 2022 · Class II · Terminated · D-1052-2022
cGMP deviations: Temperature abuse
Xylocaine + Epinephrine, multi dose vial 1%, packaged in a) 20 mL, 25-count box (NDC 63323-482-27) b) 50 mL, 25-count box (NDC 63323-482-57), Rx only, MFG: Fresenius Kabi USA LLC — Mckesson Medical-Surgical Inc. Corporate Office
-
April 13, 2022 · Class II · Terminated · D-1053-2022
cGMP deviations: Temperature abuse
Xylocaine + Epinephrine, multi dose vial 2%, 20 mL, 25 count box, Rx only, MFG: Fresenius Kabi USA LLC, NDC 63323-483-27 — Mckesson Medical-Surgical Inc. Corporate Office
-
November 30, 2021 · Class II · Ongoing · D-0296-2022
Superpotent Drug: Minimally superpotent
Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, — Teligent Pharma, Inc.
-
November 30, 2021 · Class I · Ongoing · D-0295-2022
Superpotent Drug
Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, — Teligent Pharma, Inc.
-
October 12, 2021 · Class II · Terminated · D-0279-2022
CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Manufactured by: Teligent Pharma Inc., Buena, NJ 06310, Distributed by: McKesson Corporation dba Sky Packaging, 497 Southridge Blv — Teligent Pharma, Inc.
-
June 25, 2021 · Class II · Terminated · D-0651-2021
Low out of specification results for epinephrine assay.
Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. — Fresenius Kabi USA LLC
-
May 3, 2021 · Class I · Terminated · D-0627-2021
Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP
1% Lidocaine HCl Injection, USP, 300 mg/30 mL (10 mg/mL), 30 mL Single-dose vial (NDC 0409-4279-16), packaged in 25 vials per tray (NDC 0409-4279-02), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. — PFIZER, INC
-
July 14, 2020 · Class II · Terminated · D-1492-2020
Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30 — Teva Pharmaceuticals USA
-
November 11, 2019 · Class II · Terminated · D-0573-2020
Presence of Foreign Substance: Foreign material found inside the vial.
Lidocaine HCl Injection, USP, 2% 100 mg/5 mL (20 mg/mL), Preservative-Free, packaged in 10 x 5 mL Single Dose Vials per carton, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ — AuroMedics Pharma LLC
-
March 28, 2019 · Class I · Terminated · D-1248-2019
Presence of Particulate Matter: One vial was found to contain a hair.
Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05 — Aurobindo Pharma USA Inc.
-
April 30, 2018 · Class III · Terminated · D-0857-2018
Failed Stability Specifications
Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30) — Teva Pharmaceuticals USA
-
August 25, 2015 · Class II · Ongoing · D-1815-2015
Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.
1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free, Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-4279-02 — Hospira, Inc.
Showing the newest 25 of 31.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| RxCUI (RxNorm) | 1009462, 1010033, 1010035, 1010671, 1010673, 1010688, 1010692, 1010739, 1010745, 1010749 … (+10) |
|---|---|
| SPL set ID of the quoted label | 94155012-b1fc-430a-a1f5-30c21f4a3f80 |
| FDA labels (SPL) | 275 |
| FDA applications | NDA006488, NDA017584, NDA018461, NDA020612, NDA022221, NDA207962, NDA215029, 61 ANDA |
| Active ingredients (FDA) | LIDOCAINE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Xylocaine, Sportpharm LLC, effective February 3, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →